These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 3907895)

  • 1. The diagnostic value of the 24 hour integrated concentration of plasma aldosterone.
    Zadik Z; Levin P; Kowarski A
    Clin Exp Hypertens A; 1985; 7(9):1233-42. PubMed ID: 3907895
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of primary aldosteronism by the 6-hour integrated aldosterone/renin ratio.
    Zadik Z; Levin PA; Hamilton BP; Kowarski AA
    Hypertension; 1986 Apr; 8(4):285-9. PubMed ID: 3514448
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The integrated concentration of plasma renin activity and aldosterone in essential hypertension.
    Kowarski AA; Edwin CM; Akesode AP; Piotrowski LS; Hamilton BP
    Johns Hopkins Med J; 1978 Feb; 142(2):35-8. PubMed ID: 625094
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outpatient screening tests for primary aldosteronism.
    Dunn PJ; Espiner EA
    Aust N Z J Med; 1976 Apr; 6(2):131-5. PubMed ID: 1067811
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aldosterone Levels, Aortic Stiffness, and Wave Reflection in Essential Hypertensive Patients.
    Tzamou V; Kyvelou SM; Karpanou E; Petras D; Vyssoulis G
    Am J Hypertens; 2015 Jul; 28(7):852-7. PubMed ID: 25542624
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of antihypertensive medication on aldosterone and renin concentration in the differential diagnosis of essential hypertension and primary aldosteronism.
    Seifarth C; Trenkel S; Schobel H; Hahn EG; Hensen J
    Clin Endocrinol (Oxf); 2002 Oct; 57(4):457-65. PubMed ID: 12354127
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Aldosterone excretion and plasma renin activity in patients with essential hypertension and with primary aldosteronism (author's transl)].
    Helber A; Meurer KA; Rosskamp E; Wambach G; Dickmans HA; Kaufmann W
    Klin Wochenschr; 1974 Oct; 52(20):966-73. PubMed ID: 4444216
    [No Abstract]   [Full Text] [Related]  

  • 8. Fludrocortisone suppression test in normal subjects, in patients with essential hypertension and in patients with various forms of aldosteronism.
    Lund JO; Nielsen MD
    Acta Endocrinol (Copenh); 1980 Jan; 93(1):100-7. PubMed ID: 6986736
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Laboratory challenges in primary aldosteronism screening and diagnosis.
    Rehan M; Raizman JE; Cavalier E; Don-Wauchope AC; Holmes DT
    Clin Biochem; 2015 Apr; 48(6):377-87. PubMed ID: 25619896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screening for primary aldosteronism in essential hypertension: diagnostic accuracy of the ratio of plasma aldosterone concentration to plasma renin activity.
    Schwartz GL; Turner ST
    Clin Chem; 2005 Feb; 51(2):386-94. PubMed ID: 15681560
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ratio of serum aldosterone to plasma renin concentration in essential hypertension and primary aldosteronism.
    Trenkel S; Seifarth C; Schobel H; Hahn EG; Hensen J
    Exp Clin Endocrinol Diabetes; 2002 Apr; 110(2):80-5. PubMed ID: 11928071
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased urinary excretion of the epithelial Na channel activator prostasin in patients with primary aldosteronism.
    Pizzolo F; Chiecchi L; Morandini F; Castagna A; Zorzi F; Zaltron C; Pattini P; Chiariello C; Salvagno G; Olivieri O
    J Hypertens; 2017 Feb; 35(2):355-361. PubMed ID: 27841781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Age dependence of the levels of plasma norepinephrine, aldosterone, renin activity and urinary vanillylmandelic acid in normal and essential hypertensives.
    Abd-Allah NM; Hassan FH; Esmat AY; Hammad SA
    Biol Res; 2004; 37(1):95-106. PubMed ID: 15174309
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Single dose captopril as a diagnostic test for primary aldosteronism.
    Lyons DF; Kem DC; Brown RD; Hanson CS; Carollo ML
    J Clin Endocrinol Metab; 1983 Nov; 57(5):892-6. PubMed ID: 6352726
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The syndromes of low-renin hypertension: "separating the wheat from the chaff".
    Kater CE; Biglieri EG
    Arq Bras Endocrinol Metabol; 2004 Oct; 48(5):674-81. PubMed ID: 15761538
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Rectal electrical potential difference and plasma aldosterone in hyperaldosteronism and low-, normal- and high-renin hypertension].
    Skrabal F; Mauser R
    Wien Klin Wochenschr; 1976 Dec; 88(23):777-81. PubMed ID: 1014711
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is aldosterone/renin ratio useful to screen a hypertensive population for primary aldosteronism?
    Hamlet SM; Tunny TJ; Woodland E; Gordon RD
    Clin Exp Pharmacol Physiol; 1985; 12(3):249-52. PubMed ID: 3896593
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma aldosterone-plasma renin activity ratio. A simple test to identify patients with primary aldosteronism.
    Lins PE; Adamson U
    Acta Endocrinol (Copenh); 1986 Dec; 113(4):564-9. PubMed ID: 3538743
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urinary tetrahydroaldosterone and aldosterone-18-glucuronide excretion in white and black normal subjects and hypertensive patients.
    Gomez-Sanchez CE; Holland OB
    J Clin Endocrinol Metab; 1981 Feb; 52(2):214-9. PubMed ID: 7462387
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of glucocorticoid administration on aldosterone excretion and plasma renin in normal subjects, in essential hypertension and in primary aldosteronism.
    Newton MA; Laragh JH
    J Clin Endocrinol Metab; 1968 Jul; 28(7):1014-22. PubMed ID: 4298943
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.